Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..9 of 9 -
per page
Order by
Respiratory; women's care; dermatology; pain relief; GI
More
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential.
More
Are you a small to medium company seeking a UK presence?
More
UK partner for strategic divestments
More
Strategic divestments of primary care sales focussed brands
More
Products for Otorinilaryngology, Pediatrics, Dermatology, Gynecology and Ophthalmology
More
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries.
More
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark.
More
New prescription drug which will be considered as complimentary product for our roflumilast COPD drug and can be sold to the same target group
More
Displaying 1..9 of 9 -
per page
Order by
Nov 2010 - 178 pages - $1,495
Nov 2011 - 7 pages - $3,835
Nov 2010 - 160 pages - $1,495
Jan 2011 - 33 pages - $500
May 2011 - 81 pages - $3,835
Jan 2011 - 28 pages - $1,000
Dec 2010 - 37 pages - $1,000
Jan 2011 - 22 pages - $500
Dec 2010 - 36 pages - $1,000
Oct 2011 - 60 pages - $500